CELF6
Basic information
Region (hg38): 15:72284727-72320157
Previous symbols: [ "BRUNOL6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CELF6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 16 | 2 | 3 |
Variants in CELF6
This is a list of pathogenic ClinVar variants found in the CELF6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-72287285-C-A | not specified | Uncertain significance (Jul 30, 2023) | ||
15-72287320-A-G | not specified | Uncertain significance (Oct 18, 2021) | ||
15-72288338-C-T | not specified | Uncertain significance (May 16, 2024) | ||
15-72288458-G-A | Benign (Jun 08, 2018) | |||
15-72288551-C-G | not specified | Uncertain significance (May 09, 2023) | ||
15-72288877-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
15-72288925-T-G | not specified | Uncertain significance (Sep 22, 2022) | ||
15-72288930-G-T | not specified | Uncertain significance (Jul 26, 2022) | ||
15-72289162-T-G | CELF6-related disorder | Likely benign (Jun 23, 2018) | ||
15-72289243-G-T | not specified | Uncertain significance (Jan 10, 2022) | ||
15-72289429-T-A | not specified | Uncertain significance (Jul 09, 2021) | ||
15-72289646-C-A | not specified | Uncertain significance (Feb 28, 2023) | ||
15-72289659-G-T | not specified | Uncertain significance (Jun 16, 2024) | ||
15-72289685-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
15-72289733-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
15-72289946-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
15-72290008-A-C | not specified | Uncertain significance (Aug 02, 2022) | ||
15-72304751-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
15-72304807-G-A | not specified | Likely benign (Apr 28, 2017) | ||
15-72315900-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
15-72319756-A-G | Benign (Jul 10, 2018) | |||
15-72319775-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
15-72319783-C-A | Benign (Jul 06, 2018) | |||
15-72319854-C-T | CELF6-related disorder | Benign (May 24, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CELF6 | protein_coding | protein_coding | ENST00000287202 | 12 | 35403 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00445 | 0.994 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.56 | 163 | 284 | 0.573 | 0.0000177 | 3044 |
Missense in Polyphen | 34 | 62.807 | 0.54134 | 640 | ||
Synonymous | 2.32 | 94 | 127 | 0.738 | 0.00000915 | 996 |
Loss of Function | 2.81 | 8 | 22.4 | 0.358 | 0.00000119 | 242 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000934 | 0.0000924 |
European (Non-Finnish) | 0.0000269 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein implicated in the regulation of pre- mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in a muscle-specific splicing enhancer (MSE)-dependent manner. Promotes also exon exclusion of INSR pre-mRNA. {ECO:0000269|PubMed:14761971}.;
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.82
Haploinsufficiency Scores
- pHI
- 0.278
- hipred
- N
- hipred_score
- 0.455
- ghis
- 0.496
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Celf6
- Phenotype
- normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;mRNA splice site selection
- Cellular component
- nucleus;cytoplasm;cytosol;ribonucleoprotein complex
- Molecular function
- RNA binding;mRNA binding